Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karim Raza

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Rheumatology (Oxford, England)|December 4, 2009
The Michael Mason prize: early rheumatoid arthritis--the window narrowsKarim Raza
Frontiers in Immunology|May 16, 2022
Perspectives of at-Risk Individuals on Preventive Intervention for Rheumatoid Arthritis: A Mini ReviewMarie Falahee, Karim Raza
Best Practice & Research. Clinical Rheumatology|February 24, 2009
Predicting the development of RA in patients with early undifferentiated arthritisKarim Raza, Andrew Filer
Annals of the Rheumatic Diseases|March 12, 2015
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?Karim Raza, Andrew Filer
RMD Open|April 9, 2021
Rheumatoid arthritis prevention: any takers?Marie Falahee, Karim Raza
The Lancet. Rheumatology|January 27, 2024
The autoimmune response as a potential target for tolerance induction before the development of rheumatoid arthritisRene Em Toes, Karim Raza
Rheumatic Diseases Clinics of North America|December 2, 2014
Preclinical inflammatory rheumatic diseases: an overview and relevant nomenclatureKarim Raza, Danielle M Gerlag
Current Opinion in Pharmacology|April 16, 2013
Right target, right place, right time: how understandings of pathogenic mechanisms are informing the treatment of rheumatic diseasesKarim Raza, Christopher D Buckley
Rheumatology (Oxford, England)|October 23, 2012
Rheumatoid arthritis: what do we mean by early?Karim Raza, Christian D Mallen
The Journal of Rheumatology|April 1, 2005
Reversing myocardial microvascular disease in a patient with rheumatoid arthritisKarim Raza, Matthew Banks, George D Kitas
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Rheumatology (Oxford, England)|December 4, 2009
The Michael Mason prize: early rheumatoid arthritis--the window narrowsKarim Raza
Frontiers in Immunology|May 16, 2022
Perspectives of at-Risk Individuals on Preventive Intervention for Rheumatoid Arthritis: A Mini ReviewMarie Falahee, Karim Raza
Best Practice & Research. Clinical Rheumatology|February 24, 2009
Predicting the development of RA in patients with early undifferentiated arthritisKarim Raza, Andrew Filer
Annals of the Rheumatic Diseases|March 12, 2015
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?Karim Raza, Andrew Filer
RMD Open|April 9, 2021
Rheumatoid arthritis prevention: any takers?Marie Falahee, Karim Raza
The Lancet. Rheumatology|January 27, 2024
The autoimmune response as a potential target for tolerance induction before the development of rheumatoid arthritisRene Em Toes, Karim Raza
Rheumatic Diseases Clinics of North America|December 2, 2014
Preclinical inflammatory rheumatic diseases: an overview and relevant nomenclatureKarim Raza, Danielle M Gerlag
Current Opinion in Pharmacology|April 16, 2013
Right target, right place, right time: how understandings of pathogenic mechanisms are informing the treatment of rheumatic diseasesKarim Raza, Christopher D Buckley
Rheumatology (Oxford, England)|October 23, 2012
Rheumatoid arthritis: what do we mean by early?Karim Raza, Christian D Mallen
The Journal of Rheumatology|April 1, 2005
Reversing myocardial microvascular disease in a patient with rheumatoid arthritisKarim Raza, Matthew Banks, George D Kitas
Pageof 22